What the Exposome Reveals About Early-Onset Cancer: 4 Axes (Diet, Microbiome, Microplastics, Metabolism) and the Unified Life-Course Model | Vol.2

Key Points

• The “exposome” — coined by Christopher Wild in 2005 — captures the totality of non-genetic exposures across a lifetime: diet, gut microbiome, chemical environment, lifestyle, stress, air quality, light/sound. It is the conceptual counterpart of the genome.
• Early-onset cancer (EOC) research now treats EOC as the integrated outcome of cumulative exposome × individual genetic susceptibility × epigenetics × microbiome. Current Obesity Reports 2026 frames this as the “unified life-course model”.
• The four most-developed evidence axes in 2025-26: (1) ultra-processed food (UPF) and a 45% increase in early-onset colorectal adenomas in women under 50; (2) Fusobacterium nucleatum reactivating LY6A+ revival stem cells to drive carcinogenesis; (3) microplastic accumulation in tumor tissue; (4) persistent endocrine disruptors (PFAS, BPA).
• Vol.2 (this article) integrates these mechanisms. Vol.3 will cover the public-health and clinical response (lower screening age, AI-based risk prediction, individualized prevention).

Introduction — Why the Exposome Matters

If the genome is “everything inherited”, the exposome is “everything experienced”. Christopher Wild proposed the term in 2005; analytical maturity (metabolomics, LC-MS, metagenomics, AI integration) made individual-level exposure profiling realistic by the early 2020s.

The exposome is typically split into three layers:

• General external: climate, air quality, urban/rural environment, socioeconomic status, education, broader stress environment.
• Specific external: diet, smoking, alcohol, exercise, infections, chemical exposures, medications (antibiotics), radiation.
• Internal: downstream metabolites, microbiome, endocrine-immune shifts, epigenetic changes — all generated within the body in response to the external layers.

EOC research focuses on how all three layers shifted from the 1960s onward — the substrate of the birth cohort effect introduced in Vol.1.

Body

1. Diet — Ultra-Processed Foods (UPF)

The strongest evidence in 2025-26 ties UPF intake to early-onset colorectal cancer (EOCRC).

The November 2025 JAMA Oncology paper by Song et al., pooling NHS, NHS II, and HPFS (>300,000 participants):

• Women under 50 with the highest UPF intake (~10 servings/day) had a 45% higher risk of conventional adenomas compared with the lowest quintile (~3 servings/day).
• Artificially sweetened beverages and sauces/condiments were the strongest contributors.
• UPFs are low in fiber, vitamins, and polyphenols; high in unhealthy fats, refined starches, and additives (emulsifiers, artificial sweeteners). The combination disrupts gut microbiota, intestinal inflammation, and colorectal carcinogenesis.

UPFs are NOVA-class-4 industrial preparations. Examples: sodas, instant noodles, processed meats, packaged snacks, cereal bars, mass-market breads/pastries, ready-made sauces. UPFs supply 50-60% of adult caloric intake in the U.S. and Europe; substantially less elsewhere, but rising.

Mechanisms:

1. Emulsifiers (polysorbate-80, carboxymethylcellulose): degrade the protective mucus layer, allowing direct bacterial-epithelial contact. Mouse models show colitis and tumor promotion.
2. Artificial sweeteners (sucralose, saccharin, aspartame): shift microbiota composition, induce glucose intolerance, drive inflammatory responses.
3. Processed meat (nitrites, N-nitroso compounds): DNA damage; IARC Group-1 carcinogen status.
4. Low-fiber load: reduced short-chain fatty acid (SCFA: butyrate, acetate, propionate) production; impaired colonocyte metabolism and barrier function.
5. High glycemic load: insulin resistance, IGF-1 signaling, chronic inflammation.

2. Gut Microbiome — The Fusobacterium nucleatum Story

Microbiome research transformed EOCRC understanding, with Fusobacterium nucleatum at the center — an oral anaerobe whose ectopic colonization of colorectal tumors repeatedly correlates with tumor progression.

The major 2024 finding (Yu et al., Journal of Clinical Investigation, November 2024):

• F. nucleatum infection reactivates LY6A+ revival stem cells (RSCs) in intestinal crypts.
• LY6A is a GPI-anchored membrane receptor; F. nucleatum binding upregulates RPS14 (ribosomal protein S14).
• This drives RSC hyperproliferation and conversion to tumor stem cells, accelerating intestinal carcinogenesis.

This is a paradigm shift: “a bacterium reprograms host stem cells to seed tumors”. Additionally, F. nucleatum:

• Uses the FadA adhesin to bind and invade epithelial cells, disrupting junctions and promoting epithelial-mesenchymal transition (EMT).
• Induces IL-1β, IL-6, TNF-α — sustaining chronic inflammation.
• Confers resistance to chemotherapy, radiotherapy, and anti-PD-1 immunotherapy.

Identical F. nucleatum strains have been recovered from saliva and tumor tissue in the same patient — establishing oral-cavity origin. Periodontal disease and oral hygiene have unexpectedly emerged as modifiable CRC risk factors.

Other oncogenic gut bacteria:

• Bacteroides fragilis (toxigenic, BFT+): fragilysin (zinc metalloprotease) activates β-catenin and IL-17–driven inflammation.
• Escherichia coli (pks+, B2 phylogroup): produces colibactin, a DNA-damaging genotoxin.
• Streptococcus gallolyticus: long known for endocarditis association; CRC linkage now established.

3. Antibiotic Exposure — The Early-Life Effect

• Childhood (especially under 1 year) antibiotic exposure can produce long-term microbiome shifts and may elevate EOCRC risk.
• Cohort studies in Europe and North America link cumulative antibiotic prescriptions to CRC risk.
• Mechanisms: loss of microbial diversity, niche depletion, opportunistic-pathogen expansion, reduced SCFA production.
• The post-1960s explosion in antibiotic use is a likely contributor to the EOC birth-cohort effect.

4. Microplastics — An Emerging Carcinogen Candidate

2025-26 research on microplastics (<5 mm) and nanoplastics (<1 μm) is advancing rapidly.

The Molecular Cancer 2025 review “Microplastics as emerging carcinogens” reports:

• Microplastics have been detected in human lung, colorectal, gastric, cervical, breast, pancreatic, prostate, and penile tumor tissues.
• Mechanisms: chronic inflammation, oxidative stress, genotoxicity, lipid metabolism disruption, tumor immune microenvironment alteration.
• Animal models show mucus-layer disruption, microbiota shifts, intestinal inflammation, and CRC promotion.
• IARC has not classified microplastics, but the cumulative animal, mechanistic, and human-tissue evidence is escalating concern.

The post-1960s expansion of plastic use spans drinking water, food packaging, clothing, atmospheric dust, and seafood. Microplastics have been documented in human blood, placenta, and breast milk — making them a physiology-level concern, not just an environmental issue.

5. Endocrine Disruptors and PFAS

• PFAS (“forever chemicals”): water-repellent coatings, non-stick cookware, food packaging. Long biological half-lives (years to decades). Linked to renal, testicular, and thyroid cancer risk. The U.S. EPA tightened drinking-water standards in 2024.
• BPA, phthalates: endocrine disruptors implicated in breast and prostate cancer risk.
• Dioxins, PCBs: legacy carcinogens; chronic dietary exposure.
• Air pollution (PM2.5, diesel exhaust): lung cancer plus systemic carcinogenic contributions.

6. Metabolic Dysregulation — Obesity, T2DM, MASLD

Another central pillar: metabolic dysregulation. Obesity rates roughly tripled in OECD countries since the 1960s, and T2DM expanded in parallel — both tracking the EOC trend.

Mechanisms:

• Chronic inflammation: adipose-derived IL-6, TNF-α, leptin drive systemic inflammation.
• Insulin resistance → hyperinsulinemia → IGF-1 signaling: pro-proliferative, anti-apoptotic.
• Hormonal shifts: adipose aromatase activity raises estrogen, increasing breast and endometrial cancer risk.
• MASLD (metabolic dysfunction-associated steatotic liver disease): hepatocellular and biliary cancer connections.
• Microbiome interaction: obesity-/T2DM-associated dysbiosis amplifies inflammation and carcinogenesis.

7. The Unified Life-Course Model

The 2026 Current Obesity Reports review “Why Is Colorectal Cancer Occurring Earlier?” integrates these threads as a “unified life-course model”:

1. Germline genetics — individual baseline susceptibility.
2. Exposome — diet, chemicals, microplastics, antibiotics, lifestyle.
3. Epigenetic age acceleration — methylation age exceeding chronological age.
4. Microbiome dysbiosis — pro-carcinogenic species expansion, SCFA collapse.
5. Multi-omics signatures — integrated transcriptome, proteome, metabolome, microbiome profiles.

The model implies EOC cannot be explained by any single carcinogen or single lifestyle factor — it is a systemic, lifelong exposure phenomenon. This becomes the scientific foundation for the individualized prevention covered in Vol.3.

My Thoughts and Outlook

The exposome’s most important contribution is to shift the framing from “find the bad actor” to “understand the cumulative network”. Because no single factor dominates, intervention must be multilayered.

First, at the individual level, diet and physical activity remain the most reproducible levers: reducing UPF, increasing fiber, cutting processed meat, maintaining healthy weight, exercising regularly — all show preventive effects across multiple EOC types.

Second, microbiome interventions (specific probiotics, dietary patterns, eventually engineered microbes or transplants) are advancing. But “the right microbiome” varies by individual, so multi-omics-based personalization is essential.

Third, environmental chemical regulation cannot be solved by individuals — public-health and regulatory action is required. PFAS limits, microplastic reduction, and additive safety re-evaluation are global priorities.

Fourth, AI- and multi-omics-based individual exposome analysis is opening paths to risk stratification and timely intervention. This is the focus of Vol.3.

Beginner’s Perspective

“Exposome” sounds technical, but it really means the whole collection of things you’ve been exposed to since birth: foods, drinks, air, clothes, medications, stress, microbes, viruses — all of it.

Genes don’t change quickly across generations, but the things people are exposed to change a lot. Anyone born after the 1960s grew up with more processed food, more antibiotics, more plastic, more polluted air, and more sitting time than earlier generations. The cumulative effect of all this is now thought to be a major driver of the rise in cancer among younger adults.

The key shift: “there is no single villain”. That changes how to think about both personal choices and public-health policy.

Science Writer’s View

Where the genome is “what we have”, the exposome is “what we encounter”. For early-onset cancer, the strongest 2026 evidence axes are: (1) UPF and a 45% increase in under-50 colorectal adenoma risk; (2) F. nucleatum-driven LY6A+ stem-cell reactivation; (3) microplastic tumor accumulation; (4) persistent chemicals (PFAS); and (5) metabolic dysregulation (obesity, T2DM, MASLD). The Current Obesity Reports 2026 “unified life-course model” integrates germline genetics × exposome × epigenetic age acceleration × microbiome dysbiosis × multi-omics signatures. EOC is increasingly understood as a cumulative exposure phenomenon, not a single-agent disease.

Expert Perspective

The Song et al. JAMA Oncology 2025 pooled NHS/NHS II/HPFS analysis demonstrates a 45% under-50 conventional-adenoma risk increase in the highest UPF quintile, with artificially sweetened beverages and condiments dominating attributable risk. Mechanisms span emulsifier-driven mucus disruption, artificial-sweetener microbiome shifts, processed-meat nitrosation, SCFA collapse, and high-glycemic IGF-1 signaling. Yu et al. (JCI 2024) describe F. nucleatum activation of LY6A+ revival stem cells via RPS14 upregulation, driving RSC hyperproliferation and tumor-stem-cell conversion — a “bacterial stem-cell reprogramming” carcinogenesis paradigm. Molecular Cancer 2025 (doi:10.1186/s12943-025-02409-4) reviews microplastic tumor-tissue accumulation, chronic inflammation, oxidative stress, genotoxicity, and tumor-immune-microenvironment perturbation. The Current Obesity Reports 2026 unified life-course model (doi:10.1007/s13679-026-00700-z) integrates germline susceptibility × cumulative exposome × epigenetic age acceleration × microbiome dysbiosis × multi-omics signatures as the formal EOCRC framework. USPSTF age-45 effects, multi-omics risk stratification, and AI exposome integration are detailed in Vol.3.